NRBO · Categories · Form 4

NRBO - SEC Form 4 insider transactions

NeuroBo Pharmaceuticals Inc. (NRBO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NRBO

• 548d
  CEO & President Kim Hyung Heon covered exercise/tax liability with 2,867 shares, decreasing direct ownership by 4% to 63,799 units (SEC Form 4)

  4 - MetaVia Inc. (0001638287) (Issuer)
• 621d
  Large owner Dong-A St Co., Ltd sold $1,526 worth of shares (407 units at $3.75), decreasing direct ownership by 0.01% to 5,347,792 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 659d
  CEO & President Kim Hyung Heon covered exercise/tax liability with 11,467 shares, decreasing direct ownership by 15% to 66,666 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Salsbury Michael was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Groves Jason L was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Koven Andrew I was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Glickman Mark A was granted 5,051 shares, increasing direct ownership by 108% to 9,740 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Strickland D Gordon was granted 5,051 shares, increasing direct ownership by 40% to 17,552 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 726d
  Tursi James Patrick was granted 5,051 shares, increasing direct ownership by 126% to 9,072 units (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 821d
  Woodworth Marshall H was granted 33,496 shares (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 912d
  Tursi James Patrick was granted 32,157 shares (SEC Form 4)

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1024d
  SEC Form 4: Kim Hyung Heon was granted 625,064 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Salsbury Michael

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Groves Jason L

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Glickman Mark A

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Kim Na Yeon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1042d
  SEC Form 4 filed by Kim Na Yeon (Amendment)

  4/A - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1406d
  SEC Form 4: E&Investment, Inc. disposed of 1,445,267 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1406d
  SEC Form 4: Kim Na Yeon disposed of 1,445,267 shares

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1451d
  SEC Form 4 filed by Kim Na Yeon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1451d
  SEC Form 4 filed by Groves Jason L

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Kim Hyung Heon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Kang Richard

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Salsbury Michael

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1454d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1582d
  SEC Form 4 filed by Strickland D Gordon

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1672d
  SEC Form 4 filed by Price Ben Gil

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)
• 1735d
  SEC Form 4 filed by Koven Andrew I

  4 - NeuroBo Pharmaceuticals, Inc. (0001638287) (Issuer)

Other NRBO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends